Thanks to our great Clients, Partners, Colleagues, Family and Friends, we’re celebrating the completion of our first year in business.
Thanks for helping to make DelveInsight a success!!
Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.
FDA Approves Eli Lilly’s Jaypirca for Relapsed Mantle Cell Lymphoma Eli Lilly has received FDA approval for Jaypirca, a non-covalent BTK inhibitor, in relapsed mantle cell lymphoma (MCL) patients who have relapsed after treatment with other drugs in the class. Adult MCL patients who have previously received at l...
Find MoreConsultancy comes from the Latin consultare, which means "to discuss." Usually, a professional providing expert advice in a specific area can be called a consultant, a group of individuals - consultancy. Business Consultancy requires dealing with a broad range of activities, and every firm or individual involved...
Find MoreEli Lilly and AbCellera announced the dosing of the patients suffering from COVID-19 with antibody candidate - LY-CoV555. LY-CoV555 is a neutralizing IgG1 monoclonal antibody (mAb) that targets the spikes of the proteins of SARS-CoV-2. So far, COVID-19 has taken the lives of more than 372,000 people g...
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.